Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study

Aneurysm Thoracic Clinical Trial

Official title:
Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study: Multi-center, Prospective, Observational, Post-Market Follow-up Study

Status Recruiting

Clinical Trial Summary

The purpose of this study is to collect clinical data on patient outcomes, evaluate the safety and performance of Ankura TAA Stent Graft System and Surpass Super Stiff Guidewire, and build clinical evidence for patients with Descending Thoracic Aneurysm (DTA) or Type B Aortic Dissection (TBAD).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05639569
Study type	Observational
Source	Lifetech Scientific (Shenzhen) Co., Ltd.
Contact	Rae Gong
Phone	+86 18820162460
Email	gongrui@lifetechmed.com
Status	Recruiting
Phase
Start date	May 3, 2023
Completion date	December 30, 2030

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02190487` - Incidence and Risk Factors of Acute Kidney Injury After Thoracic Aortic Surgery Due to Dissection	N/A
Completed	`NCT01369732` - Prevention of Acute Kidney Injury by Erythropoietin in Thoracic Aorta Surgery With Hypothermic Cardiac Arrest	Phase 4
Active, not recruiting	`NCT05030740` - French Assessment of the Relay Plus and Relay NBS Plus Thoracic Stent-Graft
Recruiting	`NCT03322033` - Feasibility of Endovascular Repair of Ascending Aortic Pathologies	N/A